nach oben

Neurological Sciences

Erschienen in:

07.04.2022 | Original Article

Genotypic and phenotypic characteristics of juvenile/adult onset vanishing white matter: a series of 14 Chinese patients

verfasst von: Yuting Ren, Xueying Yu, Bin Chen, Hefei Tang, Songtao Niu, Xingao Wang, Hua Pan, Zaiqiang Zhang

Erschienen in: Neurological Sciences | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Vanishing white matter (VWM) is one of the most prevalent leukoencephalopathies and is caused by recessive mutations in gene eIF2B1–5. The onset may vary from an antenatal disorder that is rapidly fatal to an adult-onset disorder with chronic progressive deterioration.

Methods

Based on a comprehensive study of 14 juvenile/adult patients diagnosed in our department as well as a review of 71 previously reported cases of genetically confirmed juvenile/adult-onset VWM since 2001, we attempted to delineate the clinical symptoms, disease evolution, episodic aggravation, associated symptoms, MRI findings and genotypic characteristics of adult VWM.

Results

The onset age of neuropsychiatric symptoms was 23.4 ± 10.6 years, and the mean follow-up time was 8.1 ± 4.8 years. Major clinical symptoms included headache, epilepsy, cognitive decline, cerebellar ataxia, and urinary disturbances. Episodic aggravation was found in 42.9% of the patients in our series. Molecular studies revealed fourteen novel missense mutations. Diffuse abnormal signals characterized by T1-weighted hypointensity and T2-weighted hyperintensity were observed in the supratentorial white matter.

Conclusions

The symmetrical leukoencephalopathy must be considered in patients of any age with premature ovarian failure or optic neuropathy. The VWM disease spectrum consists of characteristic imaging findings in combination with extremely wide variability in VWM patients.

Vermeulen G, Seidl R, Mercimek-Mahmutoglu S, Rotteveel JJ, Scheper GC, van der Knaap MS (2005) Fright is a provoking factor in vanishing white matter disease. Ann Neurol 57:560–563PubMedCrossRef

Scali O, Di Perri C, Federico A (2006) The spectrum of mutations for the diagnosis of vanishing white matter disease. Neurol Sci 27:271–277PubMedCrossRef

Bugiani M, Vuong C, Breur M, van der Knaap MS (2018) Vanishing white matter: a leukodystrophy due to astrocytic dysfunction. Brain Pathol 28:408–421PubMedPubMedCentralCrossRef

Keefe MD, Soderholm HE, Shih HY, Stevenson TJ, Glaittli KA, Bowles DM, Scholl E, Colby S, Merchant S, Hsu EW, Bonkowsky JL (2020) Vanishing white matter disease expression of truncated EIF2B5 activates induced stress response. Elife 10(9):e56319

Leferink PS, Breeuwsma N, Bugiani M, van der Knaap MS, Heine VM (2018) Affected astrocytes in the spinal cord of the leukodystrophy vanishing white matter. Glia 66:862–873PubMedCrossRef

Fogli A, Dionisi-Vici C, Deodato F, Bartuli A, Boespflug-Tanguy O, Bertini E (2002) A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation. Neurology 59:1966–1968PubMedCrossRef

van der Knaap MS, van Berkel CG, Herms J, van Coster R, Baethmann M, Naidu S, Boltshauser E, Willemsen MA, Plecko B, Hoffmann GF, Proud CG, Scheper GC, Pronk JC (2003) eIF2B-related disorders: antenatal onset and involvement of multiple organs. Am J Hum Genet 73:1199–1207PubMedPubMedCentralCrossRef

van der Knaap MS, Barth PG, Gabreels FJ, Franzoni E, Begeer JH, Stroink H, Rotteveel JJ, Valk J (1997) A new leukoencephalopathy with vanishing white matter. Neurology 48:845–855PubMedCrossRef

Labauge P, Horzinski L, Ayrignac X, Blanc P, Vukusic S, Rodriguez D, Mauguiere F, Peter L, Goizet C, Bouhour F, Denier C, Confavreux C, Obadia M, Blanc F, de Seze J, Fogli A, Boespflug-Tanguy O (2009) Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases. Brain 132:2161–2169PubMedCrossRef

10.

Carra-Dalliere C, Horzinski L, Ayrignac X, Vukusic S, Rodriguez D, Mauguiere F, Peter L, Goizet C, Bouhour F, Denier C, Confavreux C, Obadia M, Blanc F, de Seze J, Sedel F, Guennoc AM, Sartori E, Laplaud D, Antoine JC, Fogli A, Boespflug-Tanguy O, Labauge P (2011) Natural history of adult-onset eIF2B-related disorders: a multicentric survey of 24 cases. Rev Neurol (Paris) 167:802–811CrossRef

11.

Hamilton EMC, van der Lei HDW, Vermeulen G, Gerver JAM, Lourenco CM, Naidu S, Mierzewska H, Gemke R, de Vet HCW, Uitdehaag BMJ, Lissenberg-Witte BI, Research Group V, van der Knaap MS (2018) Natural history of vanishing white matter. Annals Neurol 84:274–288CrossRef

12.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Committee ALQA (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424PubMedPubMedCentralCrossRef

13.

Fogli A, Rodriguez D, Eymard-Pierre E, Bouhour F, Labauge P, Meaney BF, Zeesman S, Kaneski CR, Schiffmann R, Boespflug-Tanguy O (2003) Ovarian failure related to eukaryotic initiation factor 2B mutations. Am J Hum Genet 72:1544–1550PubMedPubMedCentralCrossRef

14.

Ohtake H, Shimohata T, Terajima K, Kimura T, Jo R, Kaseda R, Iizuka O, Takano M, Akaiwa Y, Goto H, Kobayashi H, Sugai T, Muratake T, Hosoki T, Shioiri T, Okamoto K, Onodera O, Tanaka K, Someya T, Nakada T, Tsuji S (2004) Adult-onset leukoencephalopathy with vanishing white matter with a missense mutation in EIF2B5. Neurology 62:1601–1603PubMedCrossRef

15.

Ohlenbusch A, Henneke M, Brockmann K, Goerg M, Hanefeld F, Kohlschutter A, Gartner J (2005) Identification of ten novel mutations in patients with eIF2B-related disorders. Hum Mutat 25:411PubMedCrossRef

16.

Peter L, Niel F, Catenoix H, Jung J, Demarquay G, Petiot P, Rudigoz RC, Boespflug-Tanguy O, Ryvlin P, Mauguiere F (2008) Acute neurological deterioration in ovarioleukodystrophy related to EIF2B mutations: pregnancy with oocyte donation is a potentially precipitating factor. Eur J Neurol 15:94–97PubMedCrossRef

17.

Lee HN, Koh SH, Lee KY, Ki CS, Lee YJ (2009) Late-onset vanishing white matter disease with compound heterozygous EIF2B5 gene mutations. Eur J Neurol 16:e42-43PubMedCrossRef

18.

Matsukawa T, Wang X, Liu R, Wortham NC, Onuki Y, Kubota A, Hida A, Kowa H, Fukuda Y, Ishiura H, Mitsui J, Takahashi Y, Aoki S, Takizawa S, Shimizu J, Goto J, Proud CG, Tsuji S (2011) Adult-onset leukoencephalopathies with vanishing white matter with novel missense mutations in EIF2B2, EIF2B3, and EIF2B5. Neurogenetics 12:259–261PubMedCrossRef

19.

Ghezzi L, Scarpini E, Rango M, Arighi A, Bassi MT, Tenderini E, De Riz M, Jacini F, Fumagalli GG, Pietroboni AM, Galimberti D, Bresolin N (2012) A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation. Neurology 79:2077–2078PubMedCrossRef

20.

La Piana R, Vanderver A, van der Knaap M, Roux L, Tampieri D, Brais B, Bernard G (2012) Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation. Arch Neurol 69:765–768PubMedPubMedCentralCrossRef

21.

van der Lei HD, Steenweg ME, Bugiani M, Pouwels PJ, Vent IM, Barkhof F, van Wieringen WN, van der Knaap MS (2012) Restricted diffusion in vanishing white matter. Arch Neurol 69:723–727PubMed

22.

Valalik I, van der Knaap MS, Scheper GC, Jobbagy A, Liptai Z, Csokay A (2012) Long-term tremor control with bilateral Vim-DBS in vanishing white matter disease. Parkinsonism Relat Disord 18:1048–1050PubMedCrossRef

23.

Zhang H, Dai L, Chen N, Zang L, Leng X, Du L, Wang J, Jiang Y, Zhang F, Wu X, Wu Y (2015) Fifteen novel EIF2B1–5 mutations identified in Chinese children with leukoencephalopathy with vanishing white matter and a long term follow-up. PLoS One 10:e0118001PubMedPubMedCentralCrossRef

24.

Shimada S, Shimojima K, Sangu N, Hoshino A, Hachiya Y, Ohto T, Hashi Y, Nishida K, Mitani M, Kinjo S, Tsurusaki Y, Matsumoto N, Morimoto M, Yamamoto T (2015) Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease. Brain Dev 37:960–966PubMedCrossRef

25.

Ibitoye RT, Renowden SA, Faulkner HJ, Scolding NJ, Rice CM (2016) Ovarioleukodystrophy due to EIF2B5 mutations. Pract Neurol 16:496–499PubMedCrossRef

26.

Lynch DS, Rodrigues Brandao de Paiva A, Zhang WJ, Bugiardini E, Freua F, Tavares Lucato L, Macedo-Souza LI, Lakshmanan R, Kinsella JA, Merwick A, Rossor AM, Bajaj N, Herron B, McMonagle P, Morrison PJ, Hughes D, Pittman A, Laura M, Reilly MM, Warren JD, Mummery CJ, Schott JM, Adams M, Fox NC, Murphy

27.

Humayun M, Khan A (2018) Case Report: Cerebral leukodystrophy and the gonadal endocrinopathy: a rare but real association. F1000Res 7:158PubMedPubMedCentralCrossRef

28.

Villar-Quiles RN, Delgado-Suarez C, Jorquera-Moya M, Arpa-Gutierrez J, Ortega-Suero G (2018) Teaching NeuroImages: Adult-onset vanishing white matter disease. Neurology 90:e1091–e1092PubMedCrossRef

29.

Barros SR, Parreira SCR, Miranda AFB, Pereira AMB, Campos NMP (2018) New Insights in Vanishing White Matter Disease: Isolated Bilateral Optic Neuropathy in Adult Onset Disease. J Neuroophthalmol 38:42–46PubMedCrossRef

30.

Accogli A, Brais B, Tampieri D, La Piana R (2019) Long-standing psychiatric features as the only clinical presentation of vanishing white matter disease. J Neuropsychiatry Clin Neurosci 31:276–279

31.

Trevisan L, Grazzini M, Cianflone A, Accogli A, Finocchi C, Capello E, Saitta L, Grandis M, Roccatagliata L, Mandich P (2021) An eleven-year history of Vanishing White Matter Disease in an adult patient with no cognitive decline and EIF2B5 mutations. A case report. Neurocase 27:452–456

32.

Xu L, Zhong M, Yang Y, Wang M, An N, Xu X, Zhu Y, Li Z, Chen H, Zhao R, Zheng X (2022) Adult-onset vanishing white matter in a patient with EIF2B3 variants misdiagnosed as multiple sclerosis. Neurol Sci 43:2659–2667

33.

Bugiani M, Boor I, Powers JM, Scheper GC, van der Knaap MS (2010) Leukoencephalopathy with vanishing white matter: a review. J Neuropathol Exp Neurol 69:987–996PubMedCrossRef

34.

Spilka R, Ernst C, Bergler H, Rainer J, Flechsig S, Vogetseder A, Lederer E, Benesch M, Brunner A, Geley S, Eger A, Bachmann F, Doppler W, Obrist P, Haybaeck J (2014) eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation. Cell Oncol (Dordr) 37:253–267CrossRef

35.

Abbink TEM, Wisse LE, Jaku E, Thiecke MJ, Voltolini-Gonzalez D, Fritsen H, Bobeldijk S, Ter Braak TJ, Polder E, Postma NL, Bugiani M, Struijs EA, Verheijen M, Straat N, van der Sluis S, Thomas AAM, Molenaar D, van der Knaap MS (2019) Vanishing white matter: deregulated integrated stress response as therapy target. Ann Clin Transl Neurol 6:1407–1422PubMedPubMedCentralCrossRef

36.

Leegwater PA, Vermeulen G, Konst AA, Naidu S, Mulders J, Visser A, Kersbergen P, Mobach D, Fonds D, van Berkel CG, Lemmers RJ, Frants RR, Oudejans CB, Schutgens RB, Pronk JC, van der Knaap MS (2001) Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet 29:383–388PubMedCrossRef

37.

van der Knaap MS, Leegwater PA, Konst AA, Visser A, Naidu S, Oudejans CB, Schutgens RB, Pronk JC (2002) Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol 51:264–270PubMedCrossRef

38.

Huber T, Herwerth M, Alberts E, Kirschke JS, Zimmer C, Ilg R (2017) Automated segmentation reveals silent radiographic progression in adult-onset vanishing white-matter disease. Neuroradiol J 30:5–9PubMedCrossRef

39.

Fogli A, Boespflug-Tanguy O (2006) The large spectrum of eIF2B-related diseases. Biochem Soc Trans 34:22–29PubMedCrossRef

40.

Mierzewska H, van der Knaap MS, Scheper GC, Jurkiewicz E, Schmidt-Sidor B, Szymanska K (2006) Leukoencephalopathy with vanishing white matter due to homozygous EIF2B2 gene mutation First Polish cases. Folia Neuropathol 44:144–148PubMed

41.

Klingelhoefer L, Misbahuddin A, Jawad T, Mellers J, Jarosz J, Weeks R, Ray Chaudhuri K (2014) Vanishing white matter disease presenting as opsoclonus myoclonus syndrome in childhood–a case report and review of the literature. Pediatr Neurol 51:157–164PubMedCrossRef

42.

Van Haren K, Bonkowsky JL, Bernard G, Murphy JL, Pizzino A, Helman G, Suhr D, Waggoner J, Hobson D, Vanderver A, Patterson MC, Consortium G (2015) Consensus statement on preventive and symptomatic care of leukodystrophy patients. Mol Genet Metab 114:516–526PubMedCrossRef

43.

Stellingwerff MD, Al-Saady ML, van de Brug T, Barkhof F, Pouwels PJW, van der Knaap MS (2021) MRI natural history of the leukodystrophy vanishing white matter. Radiology 300:671–680PubMedCrossRef

44.

Wu Y, Pan Y, Du L, Wang J, Gu Q, Gao Z, Li J, Leng X, Qin J, Wu X, Jiang Y (2009) Identification of novel EIF2B mutations in Chinese patients with vanishing white matter disease. J Hum Genet 54:74–77PubMedCrossRef

45.

Slynko I, Nguyen S, Hamilton EMC, Wisse LE, de Esch IJP, de Graaf C, Bruning JB, Proud CG, Abbink TEM, van der Knaap MS (2021) Vanishing white matter: eukaryotic initiation factor 2B model and the impact of missense mutations. Mol Genet Genomic Med 9:e1593PubMedPubMedCentralCrossRef

46.

Deng J, Zhou L, Zhang J, Chang X, Jiang Y, Wang J, Wu Y (2021) Correlation between genotype and age of onset in leukoencephalopathy with vanishing white matter. Front Genet 12:729777PubMedPubMedCentralCrossRef

47.

Maletkovic J, Schiffmann R, Gorospe JR, Gordon ES, Mintz M, Hoffman EP, Alper G, Lynch DR, Singhal BS, Harding C, Amartino H, Brown CM, Chan A, Renaud D, Geraghty M, Jensen L, Senbil N, Kadom N, Nazarian J, Yuanjian F, Zuyi W, Hartka T, Morizono H, Vanderver A (2008) Genetic and clinical heterogeneity in eIF2B-related disorder. J Child Neurol 23:205–215PubMedCrossRef

48.

Fogli A, Schiffmann R, Hugendubler L, Combes P, Bertini E, Rodriguez D, Kimball SR, Boespflug-Tanguy O (2004) Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients. Eur J Hum Genet 12:561–566PubMedCrossRef

49.

Fogli A, Schiffmann R, Bertini E, Ughetto S, Combes P, Eymard-Pierre E, Kaneski CR, Pineda M, Troncoso M, Uziel G, Surtees R, Pugin D, Chaunu MP, Rodriguez D, Boespflug-Tanguy O (2004) The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology 62:1509–1517PubMedCrossRef

50.

Singh RR, Livingston J, Lim M, Berry IR, Siddiqui A (2017) An unusual neuroimaging finding and response to immunotherapy in a child with genetically confirmed vanishing white matter disease. Eur J Paediatr Neurol 21:410–413PubMedCrossRef

51.

Zhou L, Li P, Chen N, Dai LF, Gao K, Liu YN, Shen L, Wang JM, Jiang YW, Wu Y (2019) Modeling vanishing white matter disease with patient-derived induced pluripotent stem cells reveals astrocytic dysfunction. CNS Neurosci Ther 25:759–771PubMedPubMedCentralCrossRef

52.

Wong YL, LeBon L, Basso AM, Kohlhaas KL, Nikkel AL, Robb HM, Donnelly-Roberts DL, Prakash J, Swensen AM, Rubinstein ND, Krishnan S, McAllister FE, Haste NV, O'Brien JJ, Roy M, Ireland A, Frost JM, Shi L, Riedmaier S, Martin K, Dart MJ, Sidrauski C (2019) eIF2B activator prevents neurological defects caused by a chronic integrated stress response. Elife 9(8):e42940

53.

Dooves S, Leferink PS, Krabbenborg S, Breeuwsma N, Bots S, Hillen AEJ, Jacobs G, van der Knaap MS, Heine VM (2019) Cell replacement therapy improves pathological hallmarks in a mouse model of leukodystrophy vanishing white matter. Stem Cell Reports 12:441–450PubMedPubMedCentralCrossRef

Titel: Genotypic and phenotypic characteristics of juvenile/adult onset vanishing white matter: a series of 14 Chinese patients
verfasst von: Yuting Ren
Xueying Yu
Bin Chen
Hefei Tang
Songtao Niu
Xingao Wang
Hua Pan
Zaiqiang Zhang
Publikationsdatum: 07.04.2022
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 8/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-022-06011-0

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2022

Validation of a short Italian version of the Barratt Impulsiveness Scale (BIS-15) in non-clinical subjects: psychometric properties and normative data

Italian translation and validation of fatigue symptoms and impacts questionnaire in relapsing multiple sclerosis (FSIQ-RMS)

The first case report of spinocerebellar ataxia type-40 in India: novel phenotypic and radiological (bilateral olivary degeneration) features and a comprehensive review of this remarkable radiological sign

COVID-19-associated severe mono-hemispheric encephalitis in a young infant

Olfactory dysfunction and striatal dopamine transporter binding in motor subtypes of Parkinson’s disease